SEBULSKY ALAN
SEC insider (Form 3/4/5 filer). CIK 0001092348. Director at MeiraGTx Holdings plc (MGTX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in NEW YORK, NY.
Companies SEBULSKY ALAN has filed insider reports for
- MeiraGTx Holdings plc (MGTX): Director
- Parabilis Medicines, Inc. (PBLS): Director
SEBULSKY ALAN
CIK: 0001092348
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 23, 2026MGTX
MeiraGTx Holdings plc
AwardDirectRestricted Share Units
100K shares- - Jun 15, 2026PBLS
Parabilis Medicines, Inc.
PurchaseIndirect5K shares at avg. $26.00$130K - Jun 15, 2026PBLS
Parabilis Medicines, Inc.
PurchaseIndirect4.1K shares at avg. $27.10$110K - Jun 12, 2026PBLS
Parabilis Medicines, Inc.
PurchaseIndirect8.4K shares at avg. $27.67$233K - Jun 11, 2026PBLS
Parabilis Medicines, Inc.
PurchaseIndirect12.5K shares at avg. $20.00$250K - Jun 9, 2026PBLS
Parabilis Medicines, Inc.
AwardDirectStock Option (Right to Buy)
39.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  MGTX MeiraGTx Holdings plc | Award Restricted Share Units | 100,000 | - | - | Direct |
| Jun 15, 2026 |  PBLS Parabilis Medicines, Inc. | Purchase | 5,000 | $26.00 | $129,989 | Indirect |
| Jun 15, 2026 | PBLS Parabilis Medicines, Inc. | Purchase | 4,065 | $27.10 | $110,146 | Indirect |
| Jun 12, 2026 | PBLS Parabilis Medicines, Inc. | Purchase | 8,435 | $27.67 | $233,393 | Indirect |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc. | Purchase | 12,500 | $20.00 | $250,000 | Indirect |
| Jun 9, 2026 | PBLS Parabilis Medicines, Inc. | Award Stock Option (Right to Buy) | 39,792 | - | - | Direct |
1-6 of 6 transactions